Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedExpanded and revised the Locations section by adding state site listings (CA, CO, FL, IL, MA, MO, NY, NC, OH, OK, TN, TX, WI) and removing prior state entries. This changes which study sites are listed and where participants can enroll.SummaryDifference1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not pertain to the study, and updated the revision to v3.3.2. Removed the previous note indicating PubMed publications are automatically created by ClinicalTrials.gov and linked to the study, with the revision updated to v3.2.0.SummaryDifference0.1%

- Check46 days agoChange DetectedThe funding-status notice at the top of the page was removed. This banner was a generic operating-status message not related to the study details.SummaryDifference0.2%

- Check68 days agoChange DetectedNo meaningful changes in the study details or structure are observed between the screenshots.SummaryDifference0.3%

- Check90 days agoChange Detected- Added a government operating status notice and open/operating details, plus a v3.2.0 revision marker. - Removed the previous v3.1.0 revision tag.SummaryDifference2%

- Check97 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.0%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.